Institutional investors purchased a net $4.5 million shares of VSTM during the quarter ended September 2015. This may signal that the smart money is gaining interest in this company as the 44.51% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CHOICE FINANCIAL PARTNERS, INC. Bought 407.3 Thousand shares of Verastem Inc